hydrazine has been researched along with Tremor in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BARRE, N; CAHN, J; HEROLD, M | 1 |
CLARK, WG; FLEMING, RM; HANSSON, E | 1 |
Dill, RE; Dorris, RL; Furgeson, MD | 1 |
Birkmayer, W | 1 |
Birkmayer, W; Linauer, W; Mentasti, M; Riederer, P | 1 |
Chen, SC; Kasuya, Y; Munakata, H; Watanabe, H | 1 |
Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Ohmoto, T | 1 |
Mones, RJ | 1 |
Horst, WD; Pool, WR; Spiegel, HE | 1 |
Coates, GH; Cox, B | 1 |
Alfandary, I; Hemli, JA; Siegfried, J; Wajsbort, J; Yahel, M | 1 |
Hirvonen, J; Isomäki, H; Kaila, J; Sotaniemi, E; Takkunen, J | 1 |
2 trial(s) available for hydrazine and Tremor
Article | Year |
---|---|
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Cognition Disorders; Constipation; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Feeding and Eating Disorders; Hallucinations; Humans; Huntington Disease; Hydrazines; Hypertension; Infusions, Parenteral; Injections, Intravenous; Monoamine Oxidase Inhibitors; Movement Disorders; Nausea; Norepinephrine; Parkinson Disease; Serotonin; Stimulation, Chemical; Time Factors; Tremor; Vomiting | 1971 |
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Topics: Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Dermatitis, Seborrheic; Dihydroxyphenylalanine; Drug Combinations; Drug Evaluation; Humans; Hydrazines; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Tremor | 1974 |
10 other study(ies) available for hydrazine and Tremor
Article | Year |
---|---|
[Action of different inhibitors of L-DOPA 5 HTP decarboxylase on insulin hypoglycemia in the rat].
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Antimetabolites; Cinnamates; Dopa Decarboxylase; Hydrazines; Hyperinsulinism; Hypoglycemia; Insulins; Levodopa; Rats; Seizures; Tremor | 1963 |
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
Topics: 5-Hydroxytryptophan; Amines; Aromatic-L-Amino-Acid Decarboxylases; Carbon Isotopes; Carboxy-Lyases; Dihydroxyphenylalanine; Hydrazines; Hydroxylamines; Iproniazid; Metabolism; Mice; Pharmacology; Radiometry; Research; Serotonin; Tremor | 1964 |
Importance of O-methylation in dopamine-induced motor and behavioral phenomena.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Drug Combinations; Humans; Hydrazines; Male; Methylation; Motor Activity; Movement Disorders; Rats; Reaction Time; Stereotyped Behavior; Tremor; Tropolone; Tyramine | 1976 |
Effect of L-dopa, adrenergic -blockers and anticholinergic agents on the tremorine-tremor in mice.
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Dihydroxyphenylalanine; Drug Combinations; Hydrazines; Isoproterenol; Male; Mice; Parasympatholytics; Phenethylamines; Piperidines; Propranolol; Stereoisomerism; Sympatholytics; Tranylcypromine; Tremor; Tremorine | 1971 |
Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
Topics: 5-Hydroxytryptophan; Animals; Benzyl Compounds; Dihydroxyphenylalanine; Dioxoles; Drug Interactions; Electroencephalography; Haloperidol; Haplorhini; Humans; Hydrazines; Hyperkinesis; Injections, Intraperitoneal; Methyldopa; Methyltyrosines; Picolinic Acids; Piperazines; Pyrimidines; Tremor | 1973 |
An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.
Topics: Aged; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Male; Muscle Rigidity; Muscles; Neurologic Examination; Parkinson Disease; Tremor | 1973 |
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Blepharoptosis; Brain; Catatonia; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fever; Humans; Hydrazines; Male; Mice; Mice, Inbred Strains; Norepinephrine; Oxotremorine; Parkinson Disease, Secondary; Reserpine; Time Factors; Tremor | 1973 |
Harmine tremor after brain monoamine oxidase inhibition in the mouse.
Topics: Alkaloids; Animals; Benzyl Compounds; Brain; Drug Interactions; Hydrazines; Indoles; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyridines; Tremor | 1972 |
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Topics: Aged; Benzyl Compounds; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Serine; Speech Disorders; Tremor | 1971 |
Hydrazine toxicity in the human. Report of a fatal case.
Topics: Bronchitis; Conjunctivitis; Humans; Hydrazines; Kidney; Liver; Lung; Male; Middle Aged; Nausea; Necrosis; Nephritis; Tremor | 1971 |